Biotechnology Stocks I Performance Guide: MorphoSys AG (MOR)
MOR has no dividends.
Table and Chart of MOR Performance
See what a $1,000 investment in MOR is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| MOR Returns | |
|---|---|
| Start Date | May-31-2018 |
| Start Price | $26.49 |
| End Date | Sep-06-2024 |
| End Price | $18.96 |
| # Prices | 77 |
| Min Date | Dec-30-2022 |
| Min Price | $3.58 |
| Max Date | Dec-31-2019 |
| Max Price | $35.67 |
| Total Return | -28.43% |
| Annualized Return | -5.08% |
| Current Value of $1,000 Purchase | $716 |
| Number Returns | 2,926 |
| Average Return | -17.05% |
| Number Profitable Returns | 779 |
| Percent Profitable Returns | 26.62% |
| Number Unprofitable Returns | 2,147 |
| Percent Unprofitable Returns | 73.38% |
| Profitable to Unprofitable Returns Ratio | 0.36 |
| MOR Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,024 |
| Beta | -0.313 | Price to Sales | 322.58 |
| Earnings per Share | $0.0000 |
| PE Ratio | -444867104 |
| PE to Growth Ratio | None |
| Price to Book | 11.83 |
| PRICE DATA | |
| 52 Week High | $0.662 |
| 52 Week Low | $19.5 |
| Analyst Target Price | $0.131 |
| 50-Day Moving Average | $4.185 |
| 200-Day Moving Average | $18.46 |
| FINANCIAL DATA | |
| Revenue per Share | $-1.5 |
| Revenue | $-2 |
| Profit Margin | 171.6% |
| Return on Equity | -13.8% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
MOR Compare Returns with S&P 500
MOR Trendline Chart
MOR Moving Average Chart
MOR Stock Return Map - See Patterns of Gains and Losses
MOR Stock Returns/Purchase Dates